“…Early diagnostic methods, such as 17-OHP dosage or molecular analysis of the CYP21A2 gene (in amniocytes or chorionic villi), during the eighth week of gestation 3 , can be useful to avoid genital ambiguity in females and, also, precocious pseudopuberty in males. It is useful in preventing deaths resulting from the PS form 6,7 Less common variations of CAH (10% of cases) can present other disorders ,depending on the affected enzyme, such as Systemic Arterial Hypertension (SAH), no development of secondary sexual characters, low levels of androgens, signs of little or absent virilization in boys, hypergonadotrophic hypogonadism, history of maternal virilization during pregnancy and skeletal malformations. Definitive differential diagnosis of these forms, in relation to 21-OH deficiency, are made through specific genetic tests 3 .…”